By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Clearside Biomedical 

1220 Old Alpharetta Road
Suite 300
Alpharetta   Georgia  30005  U.S.A.
Phone: 678-270-3631 Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Clearside Biomedical Announces Positive Topline Data From Phase 2 Clinical Trial For The Treatment Of Macular Edema Associated With Non-Infectious Uveitis 1/5/2016 11:27:18 AM
Clearside Biomedical Completes Enrollment In Phase 2 Clinical Trial Of CLS-TA For The Treatment Of Retinal Vein Occlusion Using Suprachoroidal Space (SCS) Drug Administration 12/14/2015 1:02:52 PM
Clearside Biomedical Enrolls First Patient In Phase 3 Clinical Trial Of CLS-TA Using Suprachoroidal Drug Administration 12/7/2015 1:06:25 PM
Clearside Biomedical Nabs $20 Million Series C Financing 12/3/2015 5:59:16 AM
Clearside Biomedical Announces Fifth Patent Issued In The U.S. Related To Proprietary Microneedle Drug Delivery Methods And Devices 11/12/2015 12:11:24 PM
Clearside Biomedical Completes Enrollment In Phase 2 Clinical Trial Of CLS-TA Using Suprachoroidal Space (SCS) Drug Administration 10/12/2015 10:34:58 AM
Clearside Biomedical Announces 50th Patient Enrolled Using Suprachoroidal Drug Administration 9/24/2015 10:22:18 AM
Clearside Biomedical To Present At The 13th Congress Of International Ocular Inflammation Society (IOIS) In San Francisco, CA 9/22/2015 10:51:57 AM
Clearside Biomedical To Present At International Symposium On Ocular Pharmacology And Therapeutics (ISOPT) Clinical Meeting 7/9/2015 8:13:24 AM
Clearside Biomedical Announces Favorable End-of-Phase 2 Review With The FDA 6/16/2015 11:30:49 AM
123
//-->